Wound healing and dermal regeneration in severe burn patients treated with NovoSorb® Biodegradable Temporising Matrix: A prospective clinical study, Lo et al. 2021.
https://www.sciencedirect.com/science/article/pii/S0305417921001996
In what may be our biggest clinical trial to date for major burns victims, Novosorb BTM stacked up well/if not better amongst its major competitors Integra, Matriderm and Glyaderm.
Wound healing and dermal regeneration in severe burn patients...
-
- There are more pages in this discussion • 7,216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
-0.120(4.63%) |
Mkt cap ! $1.704B | |||
| Open | High | Low | Value | Volume |
| $2.58 | $2.58 | $2.47 | $3.191M | 1.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 15844 | $2.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.48 | 22823 | 2 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |